Detalhe da pesquisa
1.
Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group.
Eur J Haematol;
109(3): 257-270, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35634931
2.
Long-term outcome after allogeneic stem cell transplantation in multiple myeloma.
Ann Hematol;
100(6): 1553-1567, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33866396
3.
Investigation and Management of Bone Mineral Density Following Hematopoietic Cell Transplantation: A Survey of Current Practice by the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant;
26(10): 1955-1962, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32623077
4.
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.
N Engl J Med;
374(1): 43-53, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26735993
5.
A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
Cancer;
124(4): 727-733, 2018 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29112242
6.
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease: Final Results From the International Compassionate-Use Program.
Biol Blood Marrow Transplant;
22(10): 1874-1882, 2016 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27397724
7.
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.
Ann Hematol;
95(6): 967-72, 2016 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26994010
8.
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.
Biol Blood Marrow Transplant;
20(1): 135-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24141008
9.
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Transfusion;
54(10): 2514-22, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24964911
10.
The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party.
Bone Marrow Transplant;
59(2): 255-263, 2024 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38062242
11.
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
Lancet Haematol;
11(2): e147-e159, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38184001
12.
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Blood;
117(23): 6375-82, 2011 Jun 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21467544
13.
Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study.
Bone Marrow Transplant;
58(11): 1209-1214, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37573397
14.
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).
Bone Marrow Transplant;
58(7): 749-754, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37095231
15.
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study.
J Clin Med;
11(12)2022 Jun 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35743620
16.
Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.
Haematologica;
96(9): 1344-50, 2011 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21659356
17.
Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial.
Lancet Oncol;
11(4): 331-8, 2010 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20117965
18.
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.
Biol Blood Marrow Transplant;
16(2): 157-68, 2010 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19766729
19.
Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia.
Haematologica;
95(6): 922-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20305143
20.
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Lancet Oncol;
10(9): 855-64, 2009 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19695955